Gómez-Valenzuela, F.; Wichmann, I.; Suárez, F.; Kato, S.; Ossandón, E.; Hermoso, M.; Fernández, E.A.; Cuello, M.A.
Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. Cancers 2024, 16, 80.
https://doi.org/10.3390/cancers16010080
AMA Style
Gómez-Valenzuela F, Wichmann I, Suárez F, Kato S, Ossandón E, Hermoso M, Fernández EA, Cuello MA.
Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. Cancers. 2024; 16(1):80.
https://doi.org/10.3390/cancers16010080
Chicago/Turabian Style
Gómez-Valenzuela, Fernán, Ignacio Wichmann, Felipe Suárez, Sumie Kato, Enrique Ossandón, Marcela Hermoso, Elmer A. Fernández, and Mauricio A. Cuello.
2024. "Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer" Cancers 16, no. 1: 80.
https://doi.org/10.3390/cancers16010080
APA Style
Gómez-Valenzuela, F., Wichmann, I., Suárez, F., Kato, S., Ossandón, E., Hermoso, M., Fernández, E. A., & Cuello, M. A.
(2024). Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. Cancers, 16(1), 80.
https://doi.org/10.3390/cancers16010080